Skip to content

dCDH Phase 3a: placebo SE, non-binary treatment, parity SE assertions #20

dCDH Phase 3a: placebo SE, non-binary treatment, parity SE assertions

dCDH Phase 3a: placebo SE, non-binary treatment, parity SE assertions #20